PlainRecalls

Pine Pharmaceuticals, LLC

Compiled from official public sources by the publisher.

24 recalls on record · Latest: Oct 25, 2023

Subscribe to new Pine Pharmaceuticals, LLC recalls (RSS)

Agency notice ledger

Federal filing book Pine Pharmaceuticals, LLC MID-BOOK · SINGLE-AGENCY

#685 of 14,151 · 24 notices · 0.023% archive

  • BOOK 24 notices
  • RANK #685 of 14,151
  • SHARE 0.023% archive
  • AGENCY FDA Drug (24)
  • CAT drugs
  • CATS 2 categories
  • LATEST Oct 25, 2023
  • PHOTO Bard Access Systems

Nearest notice-volume peer: Bard Access Systems (0 notice gap)

Pine Pharmaceuticals, LLC accounts for about 0.023% of the 104,423-notice archive on 24 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Pine Pharmaceuticals, LLC's standing among 14,151 recalling firms

Pine Pharmaceuticals, LLC ranks 685th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Pine Pharmaceuticals, LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

24 685th of 14151 higher than 13,456 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Pine Pharmaceuticals, LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Pine Pharmaceuticals, LLC holds about 0.023% of archive notices alongside 24 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Oct 25, 2023

Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose Vial, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Cefuroxime 4mg /0.4 mL (10 mg/mL), 1mL syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Calcium chloride Solution for Intravenous Injection, 20 mg/mL, 500 mL bags, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Lidocaine HCl 4% ophthalmic solution, 3 mL single-use dropper, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

TPC Drops (tropicamide 1%- phenylephrine 2.5%- cyclopentolate HCl 1% ophthalmic solution, 5 mL droppers, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Calcium Gluconate Ophthalmic Irrigation Solution 1%, 500 mL bags, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Calcium Gluconate 2.5% solution for inhalation, 5mL pre-filled syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Vancomycin 1 MG/0.1 ML Solution for Intraocular Injection, 0.8 ML Single Dose Vial, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Tropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic solution, 5mL multi-use dropper, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Endophth Kit (Vancomycin 1mg/0.1 mL - Ceftazidime 2.25mg/0.1 mL), Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Foscarnet Sodium 2.4mg/0.1 mL solution for injection, 0.2 mL single-dose Staclear Luer Slip Syringe, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Moderate Oct 25, 2023

Tropi-Phen (Tropicamide 1% phenylephrine HCl 2.5%) ophthalmic solution, 15 mL multi-use Droppers, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Low Apr 19, 2023

Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1
FDA Drug Moderate Jan 11, 2023

Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1
FDA Drug Moderate Sep 21, 2022

Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10 mL prefilled syringe, Item# 803, barcode 6919408031; b) 5 mL prefilled syringe, Item# 933, barcode 6919409331, Rx only, Pine Pharmaceuticals, 355 Riverwalk Parkway, Tonawanda, NY 14150.
FDA Drug Low Mar 28, 2018

Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01
FDA Drug Moderate Jan 27, 2016

Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
FDA Drug Moderate Jan 27, 2016

Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
FDA Drug Moderate Jan 27, 2016

Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
FDA Drug Moderate Jan 27, 2016

Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.

Pine Pharmaceuticals, LLC holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (24 here).

Bard Access Systems 24 Bio-Rad Laboratories, Inc. 24 Biomet 24 Bliss Bros Dairy, Inc. 24 Boba Direct, Inc. 24

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Calvin Scott & Company, Inc. 24 Gaia Ethnobotanical LLC 24 Guardian Pharmacy Services 24 Premier Pharmacy Labs Inc 24

Frequently Asked Questions

How many federal recall notices name Pine Pharmaceuticals, LLC? ▼
PlainRecalls indexes 24 distinct federal recall events naming Pine Pharmaceuticals, LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Pine Pharmaceuticals, LLC sit among other recalling firms? ▼
Pine Pharmaceuticals, LLC ranks #685 of 14,151 by distinct recall-event count among 14,151 firms in this archive (95th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Pine Pharmaceuticals, LLC's notices? ▼
FDA Drug accounts for 24 of this firm's 24 indexed notices.
What product category dominates Pine Pharmaceuticals, LLC's filing book? ▼
Filings for Pine Pharmaceuticals, LLC span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Pine Pharmaceuticals, LLC: 24 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Pine Pharmaceuticals, LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026